Results 131 to 140 of about 9,108 (216)

The value of EQ-5D-3L and EQ VAS as a patient-reported outcome measure for patients with ankylosing spondylitis in routine healthcare: an evaluation of construct validity and responsiveness based on the Swedish Rheumatology Quality Register. [PDF]

J Patient Rep Outcomes
Degerlund-Maldi K, Regardt M, Nystrand Länsman C, Larsson L, Parodis I, Heintz E.   +5 more
europepmc   +1 more source

Treatment of ankylosing spondylitis with biologics and targeted physical therapy: positive effect on chest pain, diminished chest mobility, and respiratory function [PDF]

, 2017
Bodnár, Nóra, Némethné Gyurcsik, Zsuzsanna, Szekanecz, Zoltán, Szántó, Sándor   +3 more
core   +1 more source

Clinical efficacy of tofacitinib in active ankylosing spondylitis and dynamic changes in gut microbiota: an exploratory descriptive four-case series with 16S rRNA sequencing analysis. [PDF]

Front Immunol
Wang L, Xie W, Li J, Chen J, Huang Y.
europepmc   +1 more source

Coping with rheumatic stressors in long-standing axial spondyloarthritis: association with patient and disease characteristics. [PDF]

Rheumatology (Oxford)
van Essen M, Capelusnik D, van der Heijde D, Landewé RBM, van Lankveld W, van Tubergen A, Ramiro S, Boonen A.   +7 more
europepmc   +1 more source

Efficacy and safety of Xeligekimab (GR1501) in the treatment of axial Spondyloarthritis: Results from a Phase II clinical trial. [PDF]

Rheumatol Immunol Res
Zeng X, Zhang S, Liu H, Zhao Y, Li X, Jiang Z, Xue Y, Kong N, Sun L, Liu S, Fan X, Hu J, Shen L, Xu D.   +13 more
europepmc   +1 more source

Impact of disease burden on VO₂max, physical performance and frailty in ankylosing spondylitis: a comparative cross-sectional study. [PDF]

BMJ Open
Tariq A, Ammar M, Saad A, Zadeh SAM.
europepmc   +1 more source

Diagnostic utility of serum TRACP5b for secondary osteoporosis in ankylosing spondylitis: a comparative cross-sectional study with primary osteoporosis and healthy controls. [PDF]

Clin Rheumatol
Kamal D, Fathi N, Osman AOBS, Abdalmageed AM, Galal MAA.   +4 more
europepmc   +1 more source

Ixekizumab for the treatment of psoriatic arthritis: an Italian multicentric retrospective observational study. [PDF]

Sci Rep
Gentileschi S, Terribili R, Gaggiano C, Fiorentini E, Cometi L, Cigolini C, Perrotta FM, Scriffignano S, Di Cato L, Panaccione A, Niccoli L, Cantini F, Benucci M, Li Gobbi F, Delle Sedie A, Vitale A, Lubrano E, Frediani B, Guiducci S.   +18 more
europepmc   +1 more source

Sex differences in pain-related biopsychosocial assessments in patients with axial spondyloarthritis. [PDF]

Arthritis Res Ther
van der Kraan YM, Paap D, Timmerman H, Wink F, Arends S, Reneman M, Spoorenberg A.   +6 more
europepmc   +1 more source

Correlation between BASDAI and ASDAS to evaluate the activity of patients with spondyloarthritis [PDF]

, 2018
Saadia Ait malek, Sara El Rharras, Ahmed Mougui, Houda Sahraoui, Imane El Bouchti   +4 more
openaire   +1 more source